Product NDC: | 0009-1111 |
Proprietary Name: | Camptosar |
Non Proprietary Name: | irinotecan hydrochloride |
Active Ingredient(s): | 20 mg/mL & nbsp; irinotecan hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0009-1111 |
Labeler Name: | Pharmacia and Upjohn Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020571 |
Marketing Category: | NDA |
Start Marketing Date: | 19960614 |
Package NDC: | 0009-1111-01 |
Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-1111-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
NDC Code | 0009-1111-01 |
Proprietary Name | Camptosar |
Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-1111-01) > 2 mL in 1 VIAL, SINGLE-DOSE |
Product NDC | 0009-1111 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | irinotecan hydrochloride |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960614 |
Marketing Category Name | NDA |
Labeler Name | Pharmacia and Upjohn Company |
Substance Name | IRINOTECAN HYDROCHLORIDE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |